# MicrobiomeX (Citrus Flavonoids)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/microbiomex
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Citrus sinensis peel extract, Citrus paradisi peel extract, Citrus flavonoid complex, Immature orange peel extract, Grapefruit peel flavonoids, Citrus peel bioflavonoids, Citrus microbiome support extract

## Overview

[Microbiome](/ingredients/condition/gut-health)X is a patented citrus flavonoid extract standardized to hesperidin and naringenin that selectively promotes beneficial gut bacteria by acting as a prebiotic substrate, driving short-chain fatty acid (SCFA) production. Its primary mechanism involves colonic fermentation of flavonoid polyphenols, which shifts the microbiome composition toward Lactobacillus and Bifidobacterium species while suppressing potentially harmful bacteria.

## Health Benefits

• Promotes beneficial gut bacteria growth and SCFA production (preliminary evidence from in vitro studies only)
• May support [digestive health](/ingredients/condition/gut-health) through microbiome modulation (based on in vitro fermentation studies)
• Exhibits antioxidant properties via [free radical scaveng](/ingredients/condition/antioxidant)ing (demonstrated in laboratory assays)
• Shows [anti-inflammatory](/ingredients/condition/inflammation) potential (in vitro evidence only)
• May enhance production of beneficial short-chain fatty acids including butyric acid (in vitro data)

## Mechanism of Action

[Microbiome](/ingredients/condition/gut-health)X delivers hesperidin and naringenin, which resist upper gastrointestinal absorption and reach the colon intact, where they serve as fermentable substrates for saccharolytic bacteria. Microbial [metabolism](/ingredients/condition/weight-management) converts these flavanones into smaller phenolic metabolites such as hesperetin and protocatechuic acid, which inhibit NF-κB signaling and reduce [pro-inflammatory cytokine](/ingredients/condition/inflammation) expression in colonocytes. Concurrently, increased SCFA output—particularly butyrate and propionate—activates GPR41 and GPR43 free fatty acid receptors on intestinal epithelial cells, reinforcing tight junction integrity and supporting mucosal barrier function.

## Clinical Summary

Human evidence for MicrobiomeX specifically is limited, with most mechanistic data derived from in vitro fecal fermentation studies demonstrating increased Bifidobacterium and Lactobacillus counts and elevated SCFA concentrations. A small-scale in vitro batch fermentation study using the proprietary citrus extract showed a statistically significant increase in butyrate production compared to inulin controls, though this has not been replicated in large randomized controlled trials. Broader research on dietary citrus flavonoids in human trials (n=20–60) suggests modest but measurable improvements in gut microbiome diversity and reduced markers of [intestinal permeability](/ingredients/condition/gut-health), but these findings cannot be directly extrapolated to MicrobiomeX's specific formulation and dosage. The overall evidence is preliminary and promising but insufficient to establish definitive clinical endpoints without larger, placebo-controlled human trials.

## Nutritional Profile

[Microbiome](/ingredients/condition/gut-health)X is a standardized citrus flavonoid extract, primarily derived from sweet orange (Citrus sinensis) and/or other citrus species. It is not a macronutrient source and provides negligible calories, protein, fat, or digestible carbohydrates at typical serving sizes (250–500 mg/day). Key bioactive compounds include: • Hesperidin (primary flavanone glycoside, typically standardized to ≥80–90% of total flavonoid content; approximately 200–450 mg per serving depending on product specification) • Naringin (secondary flavanone glycoside, present at lower concentrations, typically 5–15% of extract) • Minor citrus polymethoxyflavones (PMFs) such as nobiletin and tangeretin (trace to ~2–5% of extract) • Additional phenolic acids and flavonoid glycosides in small quantities. The extract is rich in polyphenolic compounds with total flavonoid content generally exceeding 90% by weight in high-quality preparations. Bioavailability notes: Citrus flavanone glycosides like hesperidin have relatively low oral bioavailability in the upper GI tract (estimated <5% absorption intact); however, they are extensively metabolized by colonic microbiota to bioactive aglycones (hesperetin, naringenin) and phenolic acid metabolites, which are then absorbed. This colonic [metabolism](/ingredients/condition/weight-management) is central to MicrobiomeX's proposed mechanism of action — the flavonoids serve as substrates/prebiotics for beneficial gut bacteria (particularly Bifidobacterium and Lactobacillus spp.), which ferment them into short-chain fatty acids (SCFAs: acetate, propionate, butyrate). The rutinoside form of hesperidin requires bacterial rhamnosidase for deglycosylation, meaning bioactivity is microbiome-dependent and varies between individuals. No significant vitamin or mineral content is present. Dietary fiber content is negligible (<1 g per serving). The product functions as a targeted polyphenol-based prebiotic rather than a conventional nutritional supplement.

## Dosage & Preparation

No clinically studied dosage ranges are available for [Microbiome](/ingredients/condition/gut-health)X as no human trials have been conducted. In vitro fermentation studies used 0.10 g/ml concentrations, but this cannot be translated to human dosing recommendations. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

MicrobiomeX is generally considered well-tolerated at typical supplemental doses of 500–1000 mg per day, with mild gastrointestinal side effects such as bloating or loose stools reported occasionally as the [gut microbiome](/ingredients/condition/gut-health) adjusts. Hesperidin, a primary active compound, can inhibit CYP3A4 and P-glycoprotein activity, creating a potential interaction with medications metabolized by these pathways, including statins, calcium channel blockers, and cyclosporine. Naringenin has demonstrated mild estrogenic activity in preclinical models, so individuals with hormone-sensitive conditions or those on hormonal therapies should consult a healthcare provider before use. Safety data during pregnancy and lactation is insufficient, and use is not recommended during these periods without medical supervision.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on [Microbiome](/ingredients/condition/gut-health)X are available. Current evidence is limited to in vitro studies using citrus peel flavonoid extracts from various cultivars (n=14) showing modulation of intestinal microbiota and SCFA production in simulated fermentation models. No PMIDs for MicrobiomeX-specific human trials are documented.

## Historical & Cultural Context

While [Microbiome](/ingredients/condition/gut-health)X itself has no specific historical use, citrus peels have been used in Traditional Chinese Medicine for centuries, particularly chenpi (dried tangerine peel), to treat digestive issues, cough, and [inflammation](/ingredients/condition/inflammation). These traditional applications are attributed to the flavonoid and polyphenol content found in citrus peels.

## Synergistic Combinations

Probiotics, Prebiotics, [Digestive Enzyme](/ingredients/condition/gut-health)s, L-Glutamine, Zinc Carnosine

## Frequently Asked Questions

### What is MicrobiomeX and how is it different from regular citrus extract?

MicrobiomeX is a patented, standardized extract derived from sweet oranges and grapefruits, specifically concentrated for the flavanones hesperidin and naringenin at defined ratios to optimize colonic fermentability. Unlike generic citrus extracts, which vary widely in polyphenol content, MicrobiomeX is manufactured to deliver consistent prebiotic activity confirmed through in vitro fermentation testing, making it a more research-relevant ingredient for gut health formulations.

### What dose of MicrobiomeX is used in research?

In vitro fermentation studies have used doses equivalent to approximately 500–1000 mg of MicrobiomeX per day to demonstrate increases in SCFA production and shifts in microbial populations toward Bifidobacterium and Lactobacillus species. Most commercial supplement products formulate MicrobiomeX at 500 mg per serving, though optimal human dosing has not yet been established through large-scale clinical trials.

### Does MicrobiomeX increase short-chain fatty acid production?

Yes, in vitro fecal fermentation studies show that MicrobiomeX increases production of butyrate and propionate specifically, which are the most metabolically significant SCFAs for colonocyte energy, gut barrier integrity, and systemic inflammation regulation. Butyrate activates histone deacetylase inhibition in colonocytes and signals through GPR109A, while propionate acts on GPR41 and GPR43 receptors to modulate insulin sensitivity and appetite-related hormones, though these effects require human trial validation.

### Can MicrobiomeX interact with medications?

Yes, hesperidin in MicrobiomeX inhibits the CYP3A4 liver enzyme and P-glycoprotein efflux transporter, which are responsible for metabolizing a wide range of drugs including atorvastatin, felodipine, and tacrolimus—potentially raising their plasma levels and side effect risk. Anyone taking prescription medications, particularly immunosuppressants, statins, or anticoagulants, should speak with a pharmacist or physician before adding MicrobiomeX to their routine.

### Is MicrobiomeX a probiotic or a prebiotic?

MicrobiomeX functions as a prebiotic, not a probiotic—it contains no live bacteria but instead provides fermentable polyphenol substrates (hesperidin and naringenin) that selectively feed and expand populations of beneficial bacteria already present in the colon, such as Bifidobacterium longum and Lactobacillus acidophilus. This distinguishes it from probiotics, which introduce live microbial strains, and from classic prebiotics like inulin, placing it in the emerging category of 'polyphenol prebiotics' with a distinct fermentation profile.

### What does the current research evidence say about MicrobiomeX's effectiveness in humans?

Most evidence for MicrobiomeX comes from in vitro (laboratory) and fermentation studies rather than human clinical trials, which limits our ability to confirm real-world effectiveness. While these preliminary studies suggest potential benefits for gut bacteria modulation and SCFA production, robust human studies are needed to establish whether these laboratory findings translate to measurable health outcomes. Current evidence is considered preliminary and should not be interpreted as definitive proof of efficacy in people.

### Can I get the same benefits of MicrobiomeX from eating citrus fruits instead of taking a supplement?

While whole citrus fruits do contain flavonoids and other bioactive compounds, MicrobiomeX is a concentrated branded extract designed to deliver specific citrus flavonoid compounds in standardized amounts. Regular citrus consumption provides beneficial polyphenols, but whether whole fruit provides equivalent prebiotic effects compared to the concentrated extract is not established in clinical literature. For consistent dosing and concentration of active compounds, a supplement may provide a different profile than whole fruit sources.

### Who might benefit most from MicrobiomeX supplementation, and who should be cautious?

Individuals seeking to support their microbiome through prebiotic compounds and those interested in antioxidant support may consider MicrobiomeX, though evidence in specific populations remains limited. People with citrus allergies should avoid this ingredient, and those taking medications that may be affected by polyphenol interactions should consult a healthcare provider before use. Pregnant and nursing women should seek professional guidance before supplementing, as safety data in these populations has not been adequately established.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*